CORPORATE INTRIGUE - BAYER ASSETS

被引:0
作者
TAYLOR, KS
机构
来源
HOSPITALS & HEALTH NETWORKS | 1995年 / 69卷 / 07期
关键词
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页码:76 / 76
页数:1
相关论文
共 50 条
[41]   How to Assess Confidentiality Requirements of Corporate Assets? [J].
Cervantes, Gabriela Varona ;
Fenz, Stefan .
ICT SYSTEMS SECURITY AND PRIVACY PROTECTION, IFIP TC 11 INTERNATIONAL CONFERENCE, SEC 2014, 2014, 428 :234-241
[42]   CONCERNING MERGERS AND SALES OF ENTIRE CORPORATE ASSETS [J].
Martin, Villard .
VIRGINIA LAW REVIEW, 1931, 18 (01) :37-49
[44]   TAXATION OF SALES OF CORPORATE ASSETS IN THE COURSE OF LIQUIDATION [J].
MACLEAN, CC .
COLUMBIA LAW REVIEW, 1956, 56 (05) :641-675
[45]   CORPORATE INVESTMENT CRITERIA AND VALUATION OF RISK ASSETS [J].
LITZENBERGER, RH ;
BUDD, AP .
JOURNAL OF FINANCIAL AND QUANTITATIVE ANALYSIS, 1970, 5 (4-5) :395-419
[47]   The Effect of Interest Rates on the Value of Corporate Assets and the Risk Premia of Corporate Debt [J].
Lesseig V.P. ;
Stock D. .
Review of Quantitative Finance and Accounting, 1998, 11 (1) :5-22
[48]   The corporate members of DGIM introduce oneself: Bayer Vital GmbH [J].
Wingen, Franz-Josef .
MEDIZINISCHE KLINIK, 2007, 102 (11) :951-952
[49]   Corporate focus, residential assets, and the performance of French REITs [J].
Beaubrun-Diant, Kevin ;
Maury, Tristan-Pierre .
BULLETIN OF ECONOMIC RESEARCH, 2022, 74 (02) :599-621
[50]   COPING WITH RECAPTURE PROBLEMS IN TAXABLE SALES OF CORPORATE ASSETS [J].
COHEN, NJ .
JOURNAL OF TAXATION, 1968, 29 (03) :130-133